ارسل ملاحظاتك

ارسل ملاحظاتك لنا







Assessment of use of Calcium Carbonate as Phosphate Binder in Patients on Dialysis in Saheron Hospital

المؤلف الرئيسي: Khater, Manal Adam Abdallah (Author)
مؤلفين آخرين: El Khawad, Abdalla Omer (Advisor)
التاريخ الميلادي: 2017
موقع: ام درمان
الصفحات: 1 - 41
رقم MD: 913214
نوع المحتوى: رسائل جامعية
اللغة: الإنجليزية
الدرجة العلمية: رسالة ماجستير
الجامعة: جامعة أم درمان الاسلامية
الكلية: كلية الصيدلة
الدولة: السودان
قواعد المعلومات: Dissertations
مواضيع:
رابط المحتوى:
صورة الغلاف QR قانون

عدد مرات التحميل

2

حفظ في:
LEADER 02987nam a22003017a 4500
001 1489853
041 |a eng 
100 |9 489522  |a Khater, Manal Adam Abdallah  |e Author 
245 |a Assessment of use of Calcium Carbonate as Phosphate Binder in Patients on Dialysis in Saheron Hospital 
260 |a ام درمان  |c 2017 
300 |a 1 - 41 
336 |a رسائل جامعية 
502 |b رسالة ماجستير  |c جامعة أم درمان الاسلامية  |f كلية الصيدلة  |g السودان  |o 0141 
520 |a Background: Chronic renal failure is associated with renal osteodystrophy, which is specific abnormalities of skeletal homeostasis, in which calcium and phosphorus level in patients blood be out of balance (hypocalcaemia and hyper phosphatemia), and if it not treated can result in bone problems. Renal osteodystrophy is treated by: 1. Calcium or native vitamin D supplementation 2. Restriction of dietary phosphate 3. Use of phosphate binder (calcium carbonate, calcium acetate, sevelamer,) 4. Cinacalet 5. Renal transplantation Objective: To evaluate the use of caco3 as phosphate binder in patients on dialysis in saheron hospital- Khartoum Method: Descriptive cross-sectional study was carried out. The study population was the patients on dialysis in saheron hospital. Patients were interviewed by questionnaire asking about their use of calcium carbonate and their knowledge about correct use .then compared to the standard guidelines about use of caco3 Results: Among a total of 78 surveyed patients, (94.9) % received caco3. while rest of participants (5.1) % did not take caco3. From total participants on dialysis after stop caco3 intake 37 (41) % show joint pain and backache .while 21 (33.3) % of them with no complain. From total participants on dialysis before stop of caco3 intake 61 % had no complain. 17.1 % of participants had joint pain and backache .also in same amount of 17.1 % of participants had joint pain .only 4.9 % had backache. Conclusions: calcium carbonate intake in dialyze patients required knowledgeable and patient aware with important to take it, to improve their quality of life. 
653 |a مرضى غسيل الكلى  |a كربونات الكالسيوم  |a مستشفى ساهرون  |a السودان  |a التشخيص السريري  |a الوقاية والعلاج 
700 |9 488530  |a El Khawad, Abdalla Omer  |e Advisor 
856 |u 9818-003-016-0141-T.pdf  |y صفحة العنوان 
856 |u 9818-003-016-0141-A.pdf  |y المستخلص 
856 |u 9818-003-016-0141-C.pdf  |y قائمة المحتويات 
856 |u 9818-003-016-0141-F.pdf  |y 24 صفحة الأولى 
856 |u 9818-003-016-0141-1.pdf  |y 1 الفصل 
856 |u 9818-003-016-0141-2.pdf  |y 2 الفصل 
856 |u 9818-003-016-0141-3.pdf  |y 3 الفصل 
856 |u 9818-003-016-0141-O.pdf  |y الخاتمة 
856 |u 9818-003-016-0141-R.pdf  |y المصادر والمراجع 
930 |d y 
995 |a Dissertations 
999 |c 913214  |d 913214 

عناصر مشابهة